-
Calcium channel blocker shown to ease nerve cell damage in Parkinson’s Disease
A mouse study has found that use of Dynacirc (israpidine) — a calcium channel blocker for hypertension — eased the type of nerve cell damage seen in Parkinson’s disease, supporting a Phase 3 study now underway in this medicine and 330 Parkinson’s patients.
Click here to read a summary of the study’s results: Hypertension Medicine in Phase 3 Parkinson’s Trial Seen to Protect Nerve Cells of Mice from Damage Damage
Have you heard of this drug? What do you think about this news?
-
0 Replies
Sorry, there were no replies found.
Log in to reply.